Aghwan ZA, Sazili AQ, Alimon AR, et al
Int Immunopharmacol 142(Pt B): 113222
2 The GLP-1 programme includes access to their app with GLP-1-specific features: meal tracking focused on protein and fibre targets (1g protein per kg of starting body weight), injection logging (tracking medication, dose, injection site, and side effects), on-demand strength training videos, and a library of GLP-1-specific recipes and articles
What Is Semaglutide for Obesity Semaglutide 2.4 mg is a once-weekly injectable medication developed by Novo Nordisk, specifically approved for chronic weight management
PlexusDx requires no insurance, has no membership fees, and works with HSA/FSA accounts, making it accessible across all 50 states without coverage delays